Entering text into the input field will update the search result below

Seagen, Prometheus Biosciences fall amid news of FTC planned block of Horizon/Amgen deal

Pfizer Makes $1.95 Billion Deal With U.S. For Future COVID-19 Vaccine

Jeenah Moon/Getty Images News

Seagen (NASDAQ:SGEN), which agreed to be sold to Pfizer (NYSE:PFE) in a $43 billion deal in March, fell 6% amid reports that the Federal Trade Commission was set to challenge Amgen's (AMGN) $28 billion purchase of Horizon Therapeutics (HZNP).

Prometheus Biosciences (

Recommended For You

Related Stocks

SymbolLast Price% Chg
PFE
--
MRK
--
SGEN
--